A E.P.A. spokeswoman said in an emailed statement, “The agency does not discuss draft, deliberative documents or actions still under internal and interagency review.”
On Wednesday, the House Committee on Science, Space and Technology will hold a hearing on E.P.A.’s efforts. A top pulmonary specialist and a representative of the country’s largest nonprofit funder of research on Parkinson’s disease, the Michael J. Fox Foundation, are expected to testify that the E.P.A.’s proposed rule would eliminate the use of valuable research showing the dangers of pollution to human health.
Mr. Pruitt’s original proposal drew nearly 600,000 comments, the vast majority of them in opposition. Among them were leading public health groups and some of the country’s top scientific organizations like the American Association for the Advancement of Science.
The National Association of Pediatric Nurse Practitioners said it was “deeply concerned” that the rule would lead to the exclusion of studies, “ultimately resulting in weaker environmental and health protections and greater risks to children’s health.” The National Center for Science Education said ruling out studies that do not use open data “would send a deeply misleading message, ignoring the thoughtful processes that scientists use to ensure that all relevant evidence is considered.” The Medical Library Association and the Association of Academic Health Science Libraries said the proposal “contradicts our core values.”
Industry groups said the rule would ensure greater public understanding of the science behind regulations that cost consumers money.
“Transparency, reproducibility and application of current scientific knowledge are paramount to providing the foundation required for sound regulations,” the American Chemistry Council wrote to E.P.A. in support of the plan.
The new version does not appear to have taken any of the opposition into consideration. At a meeting of the agency’s independent science advisory board this summer, Mr. Wheeler said he was “a little shocked” at the amount of opposition to the proposal, but he was committed to finalizing it. Beyond retroactivity, the latest version stipulates that all data and models used in studies under consideration at the E.P.A. would have to be made available to the agency so it can reanalyze research itself. The politically appointed agency administrator would have wide-ranging discretion over which studies to accept or reject.
This content was originally published here.